http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_578237ad3dfb7b84ff547d29dd85a4c4
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Andrew Futreal Futreal |
| name | P Andrew Futreal P. Andrew Futreal |
| given-name | P. P Andrew P P. Andrew |
| organization-name | 2Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; MD Anderson Cancer Center, Houston, TX, USA. 1Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas, USA Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA. Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Genomic Medicine, Houston, TX, USA Genomic Medicine, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1954, Houston, TX 77030, USA. Authors' Affiliations: 1Cellular and Molecular Research, National Cancer Centre, 2Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, 3NCCS-VARI Translational Cancer Research Laboratory, National Cancer Centre, 4Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School, 5Laboratory of Computational Biology, Van Andel Research Institute, Michigan, 6Department of Physiology, National University of Singapore 7Nanyang Technological University, and 8Singapore-MIT Alliance, Singapore; 9Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, and 10Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom; 11Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan; 12Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, and 13Genome Institute of Singapore, Singapore 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. The University of Texas MD Anderson Cancer Center, Department of Genomic Medicine, Houston, TX 77030, USA. Department of Genomic Medicine The University of Texas MD Anderson Cancer Center Houston TX USA Affiliations of authors: Departments of Genetics and The Center for Genetics and Genomics (BL, XR, GL), Pathology (YM, AKEN), Head and Neck Surgery (MZ), Thoracic/Head and Neck Medical Oncology (JianjZ), and Genomic Medicine (JianjZ, JianhZ, PAF), The University of Texas MD Anderson Cancer Center, Houston, TX Authors' Affiliations: 1Translational Cancer Therapeutics Laboratory, 2Signal Transduction Laboratory, and 3High Throughput Screening Laboratory, Cancer Research UK London Research Institute, London, United Kingdom; 4University of Applied Sciences, Mathematics and Techniques, Remagen, Germany; 5Molecular and Population Genetics, The Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; 6Royal Marsden Hospital, Department of Medicine, Sutton, United Kingdom; 7Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark; 8Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, United Kingdom; and 9Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts Authors' Affiliations: 1Laboratory of Cancer Genetics, 2Laboratory of Computational Biology, Van Andel Research Institute, Grand Rapids, Michigan; Departments of 3Anatomic Pathology and 4Solid Tumor Oncology and Urology, Cleveland Clinic, Cleveland, Ohio; 5The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China; 6Department of Urology, Spectrum Health, Grand Rapids, Michigan; and 7Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.; Honorary Faculty, Wellcome Trust Sanger Institute, Hinxton, UK CB10 1SA. 1Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Trangle Park, NC 27709, USA. Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom; Department of Genomic Medicine,The University of Texas MD Anderson Cancer Center,Houston,Texas,USA Authors' Affiliations: 1MD Anderson Cancer Center and 2University of Texas-Houston Medical Center, Houston, and 3UT Southwestern Medical Center, Dallas, Texas; 4UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 5Stanford University Medical Center, Stanford, California; 6University of Toronto, Toronto, Ontario, Canada; 7McGill University, Montreal, Quebec, Canada; 8Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio; and 9Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 6Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Yuanqing Yan, Carlos Bueso-Ramos, Koji Sasaki, Ghayas C. Issa, Sa Wang, Jeffrey Jorgensen, Xingzhi Song, Jianhua Zhang, Samantha Tippen, Rebecca Thornton, Marcus Coyle, Latasha Little, Curtis Gumbs, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge E. Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Keyur P. Patel, P. Andrew Futreal, and Koichi Takahash, The University of Texas MD... 1Department of Genomic Medicine, MD Anderson Cancer Center, Houston, Texas. Departments of Obstetrics and Gynecology/Division of Gynecologic Oncology, Surgery, and Genetics, Duke University Medical Center, Durham, North Carolina Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; 6Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom; 4Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, and 5Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Department of Genomic Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States Cancer Genome Project, Wellcome Trust Sanger Institute, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, United Kingdom; Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, United Kingdom; and Cancer Research UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, United Kingdom Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom 9Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Sanger Institute, Cambridge, UK Johns Hopkins Oncology Center, 410 BBCRB, 1650 Orleans Street, Baltimore, MD 21231-1000; Center for Radiological Research, Columbia University, 630 West 168th Street, New York, NY 10032; Medical Research Center, Room 355, Duke University Medical Center, Durham, NC 27710; and Lawrence Berkeley National Laboratory, Building 934, Berkeley, CA 94720 7Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine , University of Texas MD Anderson Cancer Center Houston Texas Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 6Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom; and 1Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom; 1The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus; Department of Genomic Medicine The University of Texas MD Anderson Cancer Center Houston Texas Authors' Affiliations: Departments of 1Pathology, 2Head and Neck Surgery, 3Bioinformatics and Computational Biology, 4Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center; 5Department of Pediatrics, Baylor College of Medicine, Houston, Texas; and 6Cancer Genome Project, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX |
Incoming Links
Total number of triples: 332.